Pharmaceuticals
-
Investigation into acne medicine
An investigation has been launched into the acne medicine isotretinoin amid concerns about its psychiatric and sexual side-effects. Read more
-
New approach to tumour destroying drug
A new form of cancer immunotherapy has shown good results in a trial run by scientists at University College London, UK, it has been announced. Read more
-
Ethnicity affects COVID stroke risk – while statins may protect
The COVID-19 virus seems to double the risk of stroke for people of Asian descent, British researchers reported today. Read more
-
Synthetic nanobody could fight SARS-CoV-2 virus
A synthetic nanobody could be used to help combat COVID-19, a new study has revealed. Read more
-
Seven kinds of COVID disease?
Researchers in Austria have outlined seven distinct forms of disease in COVID-19 infection. Read more
-
Hope for new psoriasis treatment
A possible new therapy for psoriasis has shown promise, a European conference has heard. Read more
-
COVID-19 antibody therapy candidates identified
UK scientists have identified a potentially ground-breaking antibody combination that could be used as a “cocktail” against COVID-19, it is revealed today. Read more
-
Breast cancer and HRT risks evaluated
New estimates of the increased risks of breast cancer associated with different hormone replacement therapy preparations in the UK are published today. Read more
-
Drug trial for Parkinson hallucinations
An anti-nausea drug is being tested to see if it can reduce the hallucinations which affect people with Parkinson’s disease. Read more
-
Vitamin D linked to respiratory disease including COVID-19
A large proportion of patients hospitalised with COVID-19 have a deficiency of vitamin D, according to a new analysis. Read more
